Surgery Partners (NASDAQ:SGRY) Shareholder Returns Have Been Enviable, Earning 417% in 5 Years
Benchmark Co. Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $50
Benchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY)
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
Sector Update: Health Care
Surgery Partners Receives Acquisition Interest, Bloomberg Reports
Express News | TPG, UnitedHealth Among Suitors for Surgery Partners - Bloomberg News
Surgery Partners Jumps After Report of Interest From UnitedHealth, TPG
Express News | TPG, UnitedHealth Are Said Among Suitors For Surgery Partners
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Sheridan Capital Partners-Backed Oral Surgery Partners Announces Appointment of New CEO
Express News | Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $43 Price Target
Surgery Partners' Strong Q2 Performance and Upward 2024 Guidance Fuel Buy Rating
Analysts Expect Surgery Partners, Inc. (NASDAQ:SGRY) To Breakeven Soon
Express News | Surgery Partners : Barclays Cuts Target Price to $32 From $35
Surgery Partners: Strong Q2 Performance and Growth Potential Affirm Buy Rating
Surgery Partners: Balancing Solid Revenue Growth Against Free Cash Flow Concerns
Surgery Partners Is Maintained at Buy by Citigroup
Surgery Partners Price Target Maintained With a $50.00/Share by Benchmark
RBC Capital Reiterates Outperform on Surgery Partners, Maintains $49 Price Target